about
Thymectomy for non-thymomatous myasthenia gravisIgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravisPathogenesis of myasthenia gravis: update on disease types, models, and mechanismsAnimal models of myasthenia gravis: utility and limitationsPositive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewThe role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravisNeuroinflammation: Ways in Which the Immune System Affects the BrainAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesSubtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravisBiomechanical strain vehicles for fibroblast-directed skeletal myoblast differentiation and myotube functionality in a novel cocultureExpressing acetylcholine receptors after innervation suppresses spontaneous vesicle release and causes muscle fatigueAntibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays.Carbonic anhydrase III is insufficient in muscles of myasthenia gravis patients.Guidelines for treatment of autoimmune neuromuscular transmission disorders.Snake venom: From fieldwork to the clinic: Recent insights into snake biology, together with new technology allowing high-throughput screening of venom, bring new hope for drug discovery.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?Autoimmune channelopathies: new antibody-mediated disorders of the central nervous systemAlternatively spliced transcripts of the thymus-specific protease PRSS16 are differentially expressed in human thymus.Novel complement inhibitor limits severity of experimentally myasthenia gravisMyasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.Current and emerging therapies for the treatment of myasthenia gravis.Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravisThe molecular era of myology.miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis MiceSelf-representation in the thymus: an extended view.B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseasesCell therapy for autoimmune diseases: does it have a future?Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findingsProspects for a T-cell receptor vaccination against myasthenia gravis.The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders.Maternal myasthenia gravis: a cause for arthrogryposis multiplex congenita.B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.Immunology of disorders of neuromuscular transmission.
P2860
Q24197482-1723C38D-43FE-429B-ACF6-59DDD1BB73D6Q24648462-EC88C4F3-ECFE-4BA1-9635-A18585D32203Q26740634-ECD4FD97-7D88-4C85-A484-C71CFE24D099Q26750632-B22B538A-E688-4A9F-8E69-36F3941CB919Q27000682-D945D450-3262-4D71-ADE6-3F6216889952Q27008264-2B97359C-7A7A-4628-8AB3-FBD879D3A24BQ28080620-B5113F64-08B4-43C5-A263-2828E855E087Q28080791-0D0AA1EF-8D1A-4B66-80BC-48BB7AF75253Q28256140-86C9D1E0-21D4-4453-9C4D-33EBA73D8E77Q28396016-5C9D7C48-6F22-4950-B975-D6A4D8C47DC6Q29994695-3AACAA18-EE28-4D6F-B554-79BEBABE92E8Q30376254-5DD3E9C0-3E54-479C-8132-50C1D3C4E35FQ33342793-09E27E05-68B7-4F89-A35D-026CE8D0E70DQ33419952-4D6E03E5-BC01-4733-8F11-B31C4AC517CCQ33558942-73CE5E69-8ACC-450D-9390-A30A71BCA708Q33805140-66A051BA-8E6B-49DE-8584-8982B7598A93Q33871737-EEAFF0BE-FA30-4E7A-A662-49380DC62D47Q34079029-7B075E30-5722-47AB-8AC8-F3EFF4AD3505Q34167246-35A5AE40-A210-47FB-B022-2D3A2D5A8952Q34375581-204634D6-E18E-4DEA-A8FF-BAF6C7393A4CQ34604158-9B0A6FCE-9498-413F-A298-FE38D24586ABQ34618619-8E568A58-3468-4FC5-828E-991A9401C94CQ34879129-25B5A6DC-C587-4AC7-A06C-8A598362D082Q35084929-6A81446D-5DC8-4E30-8871-C5E63CC90E07Q35140467-18B5D7A8-BE65-452D-9611-C7BAEDFC47F6Q35539775-F63EE80E-6037-45A0-9A56-B5644230DA8AQ35583352-2A211DF7-75AD-4B8A-8039-C6AB4F9CC3E6Q35603050-6AF9BFAD-D148-435E-993A-D9EAE11D7B2FQ35614903-DE4F447A-6F8B-47FE-9057-EF71B11AC508Q35798566-AB074E5E-1319-4AC0-9DF3-A1EF8740296AQ35877206-E4A7D68D-1B97-4327-BB0D-AF9B97C1564CQ35903957-0D95AFA3-F13E-4179-883F-E715B65887D7Q35916008-49D23582-EC34-4EE9-BDBB-103A7F70B781Q35963139-A85D8ABA-4D56-47BC-BE68-028191747033Q36104772-E8929780-5D1B-4CE2-B0F2-C2FA02CF420AQ36238694-CD85A1B4-1B47-438C-8C62-4E1C9E454C89Q36292670-AA01EE62-F26F-44C6-BEA3-1F8F621FFB5AQ36322722-35000878-D286-4CBB-97A0-550A097D1A41Q36328407-BF81B246-1E05-4374-AB9B-478D6B246B4DQ36459475-E8198519-4EAF-452C-B06C-8B93E084192C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Unravelling the pathogenesis of myasthenia gravis.
@ast
Unravelling the pathogenesis of myasthenia gravis.
@en
Unravelling the pathogenesis of myasthenia gravis.
@nl
type
label
Unravelling the pathogenesis of myasthenia gravis.
@ast
Unravelling the pathogenesis of myasthenia gravis.
@en
Unravelling the pathogenesis of myasthenia gravis.
@nl
prefLabel
Unravelling the pathogenesis of myasthenia gravis.
@ast
Unravelling the pathogenesis of myasthenia gravis.
@en
Unravelling the pathogenesis of myasthenia gravis.
@nl
P356
P1476
Unravelling the pathogenesis of myasthenia gravis.
@en
P304
P356
10.1038/NRI916
P577
2002-10-01T00:00:00Z